MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register
{{output}}
Background: The COVID-19 pandemic affected healthcare management for people with multiple sclerosis (PwMS), leading to alterations in disease-modifying therapies (DMTs) due to concerns about COVID-19 outcomes and vaccine efficacy... ...
